Umeå University's logo

umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Physicians' gender and specialty in relation to adverse drug reaction reporting in Sweden
Umeå University, Faculty of Medicine, Department of Medical and Translational Biology.
Futurum-Academy for Healthcare, Jönköping, Sweden.
Medical Products Agency, Uppsala, Sweden.
Medical Products Agency, Uppsala, Sweden.
Show others and affiliations
2026 (English)In: European Journal of Clinical Pharmacology, ISSN 0031-6970, E-ISSN 1432-1041, Vol. 82, no 6, article id 146Article in journal (Refereed) Published
Abstract [en]

Purpose: To evaluate the possible influence of gender and specialty on adverse drug reaction (ADR) reporting among physicians before and after the COVID-19 pandemic.

Methods: This retrospective nationwide register study analysed all ADR reports submitted by physicians to the Swedish Medical Products Agency during 2017 and 2023 (n = 4079 and 3740, respectively). The reporting rates were calculated and stratified by gender and specialty.

Results: The highest reporting rate among physicians was observed in medical specialties, followed by primary care and psychiatry (27, 10, and 12, reports/100 physicians in 2017; 18, 15, and 9 in 2023). The lowest reporting rates were observed for surgical and hospital service specialties (8 and 1 in 2017; 6 and 1 in 2023). Male and female physicians reported ADRs to a similar extent and both reported more frequently on female patients. Gender concordance between physician and patient was associated with significantly higher reporting (p < 0.001 in 2017; p = 0.041 in 2023).

Conclusion: Reporting varied across specialties, and gender concordance emerged as a previously unrecognized factor influencing ADR reporting. These findings provide new opportunities for targeted interventions to enhance physician participation in pharmacovigilance.

Place, publisher, year, edition, pages
Springer Nature, 2026. Vol. 82, no 6, article id 146
Keywords [en]
Adverse drug reaction reporting systems, Gender concordance, Pharmacovigilance, Physician-patient relations, Physicians, Sex factors, Specialties, medical, Time factors
National Category
Pharmacology and Toxicology
Identifiers
URN: urn:nbn:se:umu:diva-253522DOI: 10.1007/s00228-026-04077-9ISI: 001759040400002PubMedID: 42098474Scopus ID: 2-s2.0-105038177136OAI: oai:DiVA.org:umu-253522DiVA, id: diva2:2062909
Funder
Umeå UniversityRegion VästerbottenAvailable from: 2026-05-27 Created: 2026-05-27 Last updated: 2026-05-27Bibliographically approved

Open Access in DiVA

fulltext(823 kB)14 downloads
File information
File name FULLTEXT01.pdfFile size 823 kBChecksum SHA-512
9c86749ca221c10b757b77415c6e3eb5e41a597e59c17a31f56991cd27f0604a5b1f5a88399075aaa1f1ecee756befae7bb05507623de76bb1ae8f9d69daa66a
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

Nordvall, Lina-MariaKling, Anders

Search in DiVA

By author/editor
Nordvall, Lina-MariaKling, Anders
By organisation
Department of Medical and Translational BiologyChild and Adolescent Psychiatry
In the same journal
European Journal of Clinical Pharmacology
Pharmacology and Toxicology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 43 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf